Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast 2024-2030

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast 2024-2030


Summary

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.
23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.

According to APO Research, The global 23-Valent Pneumococcal Polysaccharide Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for 23-Valent Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for 23-Valent Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for 23-Valent Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for 23-Valent Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine include MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for 23-Valent Pneumococcal Polysaccharide Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of 23-Valent Pneumococcal Polysaccharide Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for 23-Valent Pneumococcal Polysaccharide Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the 23-Valent Pneumococcal Polysaccharide Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global 23-Valent Pneumococcal Polysaccharide Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for 23-Valent Pneumococcal Polysaccharide Vaccine sales, projected growth trends, production technology, application and end-user industry.

23-Valent Pneumococcal Polysaccharide Vaccine segment by Company

MSD
Sanofipasteur
CDIBP
23-Valent Pneumococcal Polysaccharide Vaccine segment by Type

Single Dose Vial
Pre-filled Syringe
23-Valent Pneumococcal Polysaccharide Vaccine segment by Application

For Children (2-10)
For Person (10-64)
For The Old (Above or equal to 65)
23-Valent Pneumococcal Polysaccharide Vaccine segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 23-Valent Pneumococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 23-Valent Pneumococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 23-Valent Pneumococcal Polysaccharide Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of 23-Valent Pneumococcal Polysaccharide Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 23-Valent Pneumococcal Polysaccharide Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Market by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 23-Valent Pneumococcal Polysaccharide Vaccine Market by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (Above or equal to 65)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 23-Valent Pneumococcal Polysaccharide Vaccine Market Dynamics
2.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Industry Drivers
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Industry Restraints
3 Global Market Growth Prospects
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2024)
3.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2025-2030)
3.2.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
3.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2024)
3.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2025-2030)
3.4.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers, Product Type & Application
4.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market CR5 and HHI
4.8.2 2023 23-Valent Pneumococcal Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
5 23-Valent Pneumococcal Polysaccharide Vaccine Market by Type
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type
5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2030) & (K Dose)
5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2030)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type
6 23-Valent Pneumococcal Polysaccharide Vaccine Market by Application
6.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application
6.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
6.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2030) & (K Dose)
6.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2030)
6.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application
7 Company Profiles
7.1 MSD
7.1.1 MSD Comapny Information
7.1.2 MSD Business Overview
7.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
7.1.5 MSD Recent Developments
7.2 Sanofipasteur
7.2.1 Sanofipasteur Comapny Information
7.2.2 Sanofipasteur Business Overview
7.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
7.2.5 Sanofipasteur Recent Developments
7.3 CDIBP
7.3.1 CDIBP Comapny Information
7.3.2 CDIBP Business Overview
7.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
7.3.5 CDIBP Recent Developments
8 North America
8.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
8.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2030)
8.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2030)
8.1.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2019-2030)
8.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
8.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2030)
8.2.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2030)
8.2.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2019-2030)
8.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
8.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
9.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2030)
9.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2030)
9.1.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2019-2030)
9.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
9.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2030)
9.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2030)
9.2.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2019-2030)
9.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
9.3.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
10.1.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2030)
10.1.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2030)
10.1.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2019-2030)
10.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
10.2.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2030)
10.2.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2030)
10.2.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
11.1.1 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2030)
11.1.2 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2030)
11.1.3 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2019-2030)
11.2 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
11.2.1 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2030)
11.2.2 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2030)
11.2.3 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2019-2030)
11.3 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
11.3.1 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia 23-Valent Pneumococcal Polysaccharide Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
12.1.1 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2030)
12.1.3 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2019-2030)
12.2 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
12.2.1 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2030)
12.2.3 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2019-2030)
12.3 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
12.3.1 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA 23-Valent Pneumococcal Polysaccharide Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 23-Valent Pneumococcal Polysaccharide Vaccine Value Chain Analysis
13.1.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 23-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process
13.2 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
13.2.3 23-Valent Pneumococcal Polysaccharide Vaccine Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings